Rotavirus vaccine trivalent (China National Biotec Group)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRotavirus vaccine trivalent (China National Biotec Group)
Drug Alias Name轮状病毒疫苗三价 - 国药中生集团Trivalent genetic reassortment vaccine
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesChina National Biotec Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChina National Biotec Group Co Ltd
Inactive CompaniesN/A
Active IndicationsRotavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A